Core Insights - Insmed Incorporated is a global biopharmaceutical company focused on delivering first- and best-in-class therapies for patients with serious diseases [2][4] - The company has a diverse portfolio that includes approved and investigational medicines, particularly in pulmonary and inflammatory conditions [2][4] - Insmed has been recognized as a top employer in the biopharmaceutical industry, ranking No. 1 on Science's 2025 Top Biopharma Employers List [5] Company Overview - Insmed is headquartered in Bridgewater, New Jersey, with offices and research locations across the United States, Europe, and Japan [3] - The company is committed to advancing innovative therapies, including gene therapy and AI-driven protein engineering [2] Upcoming Events - Insmed will present at the Jefferies Global Healthcare Conference in London on November 18, 2025, and at the Evercore 8 Annual Healthcare Conference in Coral Gables, Florida, on December 2, 2025 [6]
Insmed To Present at November and December 2025 Investor Conferences